Oxaliplatine Kabi

Oxaliplatin, the active ingredient in Oxaliplatine Kabi, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliplatine Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Oxaliplatine Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Oxaliplatin is a platinum‑based chemotherapy drug that interferes ​         ​      ​      ​     ​                   ​             ​ ​                               ​